N-[5-[7-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-2-yl]-2-pyridinyl]-1-[4-isocyano-3-(trifluoromethyl)phenyl]piperidine-4-carboxamide

C45H48F3N9O5 — CID 169319803

IUPACN-[5-[7-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-2-yl]-2-pyridinyl]-1-[4-isocyano-3-(trifluoromethyl)phenyl]piperidine-4-carboxamide
SMILES[C-]#[N+]c1ccc(N2CCC(C(=O)Nc3ccc(N4CC5(CCN(CC6CCN(c7ccc8c(c7)C(=O)N(C7CCC(=O)NC7=O)C8=O)CC6)CC5)C4)cn3)CC2)cc1C(F)(F)F
InChIInChI=1S/C45H48F3N9O5/c1-49-36-6-3-31(23-35(36)45(46,47)48)55-18-12-29(13-19-55)40(59)51-38-8-4-32(24-50-38)56-26-44(27-56)14-20-53(21-15-44)25-28-10-16-54(17-11-28)30-2-5-33-34(22-30)43(62)57(42(33)61)37-7-9-39(58)52-41(37)60/h2-6,8,22-24,28-29,37H,7,9-21,25-27H2,(H,50,51,59)(H,52,58,60)
InChIKeyBNVYRQMTEURMII-UHFFFAOYSA-N
MW851.93 g/mol
LogP5.73
Rot. Bonds8

About N-[5-[7-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-2-yl]-2-pyridinyl]-1-[4-isocyano-3-(trifluoromethyl)phenyl]piperidine-4-carboxamide

N-[5-[7-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-2-yl]-2-pyridinyl]-1-[4-isocyano-3-(trifluoromethyl)phenyl]piperidine-4-carboxamide (PubChem CID 169319803) has the molecular formula C45H48F3N9O5 and a molecular weight of 851.93 g/mol. Its IUPAC name is N-[5-[7-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-2-yl]-2-pyridinyl]-1-[4-isocyano-3-(trifluoromethyl)phenyl]piperidine-4-carboxamide.

Molecular Properties

Compound NameN-[5-[7-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-2-yl]-2-pyridinyl]-1-[4-isocyano-3-(trifluoromethyl)phenyl]piperidine-4-carboxamide
PubChem CID169319803
Molecular FormulaC45H48F3N9O5
Molecular Weight851.93 g/mol
Exact Mass851.37
IUPAC NameN-[5-[7-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-2-yl]-2-pyridinyl]-1-[4-isocyano-3-(trifluoromethyl)phenyl]piperidine-4-carboxamide
SMILES[C-]#[N+]c1ccc(N2CCC(C(=O)Nc3ccc(N4CC5(CCN(CC6CCN(c7ccc8c(c7)C(=O)N(C7CCC(=O)NC7=O)C8=O)CC6)CC5)C4)cn3)CC2)cc1C(F)(F)F
InChIInChI=1S/C45H48F3N9O5/c1-49-36-6-3-31(23-35(36)45(46,47)48)55-18-12-29(13-19-55)40(59)51-38-8-4-32(24-50-38)56-26-44(27-56)14-20-53(21-15-44)25-28-10-16-54(17-11-28)30-2-5-33-34(22-30)43(62)57(42(33)61)37-7-9-39(58)52-41(37)60/h2-6,8,22-24,28-29,37H,7,9-21,25-27H2,(H,50,51,59)(H,52,58,60)
InChIKeyBNVYRQMTEURMII-UHFFFAOYSA-N
XLogP5.73
TPSA142.86 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds8
Heavy Atoms62
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500851.93
LogP ≤ 55.73
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[5-[7-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-2-yl]-2-pyridinyl]-1-[4-isocyano-3-(trifluoromethyl)phenyl]piperidine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[5-[7-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-2-yl]-2-pyridinyl]-1-[4-isocyano-3-(trifluoromethyl)phenyl]piperidine-4-carboxamide?
The IUPAC name of N-[5-[7-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-2-yl]-2-pyridinyl]-1-[4-isocyano-3-(trifluoromethyl)phenyl]piperidine-4-carboxamide (CID 169319803) is N-[5-[7-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-2-yl]-2-pyridinyl]-1-[4-isocyano-3-(trifluoromethyl)phenyl]piperidine-4-carboxamide.
What is the SMILES notation for N-[5-[7-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-2-yl]-2-pyridinyl]-1-[4-isocyano-3-(trifluoromethyl)phenyl]piperidine-4-carboxamide?
The canonical SMILES for N-[5-[7-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-2-yl]-2-pyridinyl]-1-[4-isocyano-3-(trifluoromethyl)phenyl]piperidine-4-carboxamide is [C-]#[N+]c1ccc(N2CCC(C(=O)Nc3ccc(N4CC5(CCN(CC6CCN(c7ccc8c(c7)C(=O)N(C7CCC(=O)NC7=O)C8=O)CC6)CC5)C4)cn3)CC2)cc1C(F)(F)F.
What is the InChIKey of N-[5-[7-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-2-yl]-2-pyridinyl]-1-[4-isocyano-3-(trifluoromethyl)phenyl]piperidine-4-carboxamide?
The InChIKey is BNVYRQMTEURMII-UHFFFAOYSA-N. The full InChI is InChI=1S/C45H48F3N9O5/c1-49-36-6-3-31(23-35(36)45(46,47)48)55-18-12-29(13-19-55)40(59)51-38-8-4-32(24-50-38)56-26-44(27-56)14-20-53(21-15-44)25-28-10-16-54(17-11-28)30-2-5-33-34(22-30)43(62)57(42(33)61)37-7-9-39(58)52-41(37)60/h2-6,8,22-24,28-29,37H,7,9-21,25-27H2,(H,50,51,59)(H,52,58,60).
What are the key properties of N-[5-[7-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-2-yl]-2-pyridinyl]-1-[4-isocyano-3-(trifluoromethyl)phenyl]piperidine-4-carboxamide?
N-[5-[7-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-2-yl]-2-pyridinyl]-1-[4-isocyano-3-(trifluoromethyl)phenyl]piperidine-4-carboxamide has a molecular weight of 851.93 g/mol, XLogP of 5.73, 8 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-[7-[[1-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-5-yl]piperidin-4-yl]methyl]-2,7-diazaspiro[3.5]nonan-2-yl]-2-pyridinyl]-1-[4-isocyano-3-(trifluoromethyl)phenyl]piperidine-4-carboxamide is sourced from PubChem (CID 169319803), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).